Samples(25500)were collected from a selective catalytic reduction(SCR)denitrification system in a fluid catalytic cracking unit and preprocessed using the quartile method and the K-nearest neighbors interpolation meth...Samples(25500)were collected from a selective catalytic reduction(SCR)denitrification system in a fluid catalytic cracking unit and preprocessed using the quartile method and the K-nearest neighbors interpolation method to remove outliers.Using the Pearson correlation coefficient and LightGBM feature score method,13 key operational variables were identified and used to establish a model to predict outlet nitrogen oxide(NO_(x))concentration in an SCR system with backpropagation neural network,long short-term memory(LSTM)and LSTM-attention fully connected(FC)model,respectively.The LSTM-attention FC model showed better accuracy and generalization capability compared with other models.Its mean square error,mean absolute error,and coefficient of determination on the training and test datasets were 11.32 and 12.51,3.65%and 3.97%,and 0.96 and 0.94,respectively.Furthermore,a combination of the LSTM-attention FC model with a genetic algorithm used to optimize four feature variables including ammonia pressure compensation,inlet pressure,gas inlet upper temperature,and outlet ammonia concentration.The outlet NO_(x)concentration could be controlled below 80±3 mg/m^(3),and the ammonia slip concentration could be controlled below 0.1 mg/m^(3),demonstrating that the optimization model can provide effective guidance for reducing NO_(x)emissions and ammonia slip of SCR systems.展开更多
IgA Fc受体(FcαRI,CD89)属于免疫受体家族成员,主要表达于单核-巨噬细胞、中性粒细胞、嗜酸性粒细胞和树突状细胞等免疫效应细胞表面。FcαRI能特异的与血清型和分泌型IgA结合,并通过γ链介导一系列免疫反应,包括抗体依赖细胞介导的细...IgA Fc受体(FcαRI,CD89)属于免疫受体家族成员,主要表达于单核-巨噬细胞、中性粒细胞、嗜酸性粒细胞和树突状细胞等免疫效应细胞表面。FcαRI能特异的与血清型和分泌型IgA结合,并通过γ链介导一系列免疫反应,包括抗体依赖细胞介导的细胞毒性作用(ADCC)、补体依赖的细胞毒性(CDC)及细胞吞噬作用等。FcαRI是一种双功能受体,在不同的生理条件下可以介导免疫系统的活化和抑制反应。FcαRI在机体免疫防御和在维持系统免疫平衡方面扮演着重要的角色,有望成为治疗人类疾病的新靶点。本文对FcαRI的结构、功能及其应用等研究现状进行综述。展开更多
详尽介绍和阐述了一种应用于W orldF IP FCS的基于对象模型的策略组态软件的研制。系统阐述了该策略组态软件的结构和组成,讨论了该策略组态软件的组态模式。提出了一种基于对象模型的FCS组态软件设计模式,详尽给出了该组态软件基于对...详尽介绍和阐述了一种应用于W orldF IP FCS的基于对象模型的策略组态软件的研制。系统阐述了该策略组态软件的结构和组成,讨论了该策略组态软件的组态模式。提出了一种基于对象模型的FCS组态软件设计模式,详尽给出了该组态软件基于对象模型的研制方法。在最后给出了一个具体的应用实例。展开更多
Shortage of appropriate donor grafts is the foremost current problem in organ transplantation. As a logical consequence, waiting times have extended and pretransplant mortality rates were significantly increasing. The...Shortage of appropriate donor grafts is the foremost current problem in organ transplantation. As a logical consequence, waiting times have extended and pretransplant mortality rates were significantly increasing. The implementation of a priority-based liver allocation system using the model of end-stage liverdisease(MELD) score helped to reduce waiting list mortality in liver transplantation(LT). However, due to an escalating organ scarcity, pre-LT MELD scores have significantly increased and liver recipients became more complex in recent years. This has finally led to posttransplant decreasing survival rates, attributed mainly to elevated rates of infectious and immunologic complications. To meet this challenging development, an increasing number of extended criteria donor grafts are currently accepted, which may, however, aggravate the patients' infectious and immunologic risk profiles. The administration of intravenous immunoglobulins(IVIg) is an established treatment in patients with immune deficiencies and other antibody-mediated diseases. In addition, IVIg was shown to be useful in treatment of several disorders caused by deterioration of the cellular immune system. It proved to be effective in preventing hyperacute rejection in highly sensitized kidney and heart transplants. In the liver transplant setting, the administration of specific Ig against hepatitis B virus is current standard in post-LT antiviral prophylaxis. The mechanisms of action of IVIg are complex and not fully understood. However, there is increasing experimental and clinical evidence that IVIg has an immuno-balancing impact by a combination of immuno-supporting and immuno-suppressive properties. It may be suggested that, especially in the context of a worsening organ shortage with all resulting clinical implications, liver transplant patients should benefit from immuno-regulatory capabilities of IVIg. In this review, perspectives of immune modulation by IVIg and impact on outcome in liver transplant patients are described.展开更多
Enterovirus （EV71） can cause severe neurological diseases, but the underlying pathogenesis remains unclear. The capsid protein, viral protein 1 （VP1）, plays a critical role in the pathogenicity of EVT1. High level...Enterovirus （EV71） can cause severe neurological diseases, but the underlying pathogenesis remains unclear. The capsid protein, viral protein 1 （VP1）, plays a critical role in the pathogenicity of EVT1. High level expression and secretion ofVP 1 protein are necessary for structure, function and immunogenicity in its natural conformation. In our previous studies, 5 codon-optimized VP 1 DNA vaccines, including wt-VP 1, tPA-VP 1, VP l-d, VP 1-hFc and VP 1 - mFc, were constructed and analyzed. They expressed VP1 protein, but the levels of secretion and immunogenicity of these VP1 constructs were significantly different （P〈0.05）. In this study, we further investigated the protein lev- els of these constructs and determined that all of these constructs expressed VP1 protein. The secretion level was increased by including a tPA leader sequence, which was further increased by fusing human IgG Fc （hFc） to VP1. VP 1-hFc demonstrated the most potent immunogenicity in mice. Furthermore, hFc domain could be used to purify VPI-hFc protein for additional studies.展开更多
基金This work was supported by the SINOPEC:Development of Remote Diagnosis Technology for FCC Flue Gas Desulfurization and Denitrification(320076).
文摘Samples(25500)were collected from a selective catalytic reduction(SCR)denitrification system in a fluid catalytic cracking unit and preprocessed using the quartile method and the K-nearest neighbors interpolation method to remove outliers.Using the Pearson correlation coefficient and LightGBM feature score method,13 key operational variables were identified and used to establish a model to predict outlet nitrogen oxide(NO_(x))concentration in an SCR system with backpropagation neural network,long short-term memory(LSTM)and LSTM-attention fully connected(FC)model,respectively.The LSTM-attention FC model showed better accuracy and generalization capability compared with other models.Its mean square error,mean absolute error,and coefficient of determination on the training and test datasets were 11.32 and 12.51,3.65%and 3.97%,and 0.96 and 0.94,respectively.Furthermore,a combination of the LSTM-attention FC model with a genetic algorithm used to optimize four feature variables including ammonia pressure compensation,inlet pressure,gas inlet upper temperature,and outlet ammonia concentration.The outlet NO_(x)concentration could be controlled below 80±3 mg/m^(3),and the ammonia slip concentration could be controlled below 0.1 mg/m^(3),demonstrating that the optimization model can provide effective guidance for reducing NO_(x)emissions and ammonia slip of SCR systems.
文摘Shortage of appropriate donor grafts is the foremost current problem in organ transplantation. As a logical consequence, waiting times have extended and pretransplant mortality rates were significantly increasing. The implementation of a priority-based liver allocation system using the model of end-stage liverdisease(MELD) score helped to reduce waiting list mortality in liver transplantation(LT). However, due to an escalating organ scarcity, pre-LT MELD scores have significantly increased and liver recipients became more complex in recent years. This has finally led to posttransplant decreasing survival rates, attributed mainly to elevated rates of infectious and immunologic complications. To meet this challenging development, an increasing number of extended criteria donor grafts are currently accepted, which may, however, aggravate the patients' infectious and immunologic risk profiles. The administration of intravenous immunoglobulins(IVIg) is an established treatment in patients with immune deficiencies and other antibody-mediated diseases. In addition, IVIg was shown to be useful in treatment of several disorders caused by deterioration of the cellular immune system. It proved to be effective in preventing hyperacute rejection in highly sensitized kidney and heart transplants. In the liver transplant setting, the administration of specific Ig against hepatitis B virus is current standard in post-LT antiviral prophylaxis. The mechanisms of action of IVIg are complex and not fully understood. However, there is increasing experimental and clinical evidence that IVIg has an immuno-balancing impact by a combination of immuno-supporting and immuno-suppressive properties. It may be suggested that, especially in the context of a worsening organ shortage with all resulting clinical implications, liver transplant patients should benefit from immuno-regulatory capabilities of IVIg. In this review, perspectives of immune modulation by IVIg and impact on outcome in liver transplant patients are described.
基金supported by the National Natural Science Foundation of China(Grant No.81000725 and 31470889)the Priority Academic Program of Basic Medical Science of Nanjing Medical University(Grant No.JX10131801060)
文摘Enterovirus （EV71） can cause severe neurological diseases, but the underlying pathogenesis remains unclear. The capsid protein, viral protein 1 （VP1）, plays a critical role in the pathogenicity of EVT1. High level expression and secretion ofVP 1 protein are necessary for structure, function and immunogenicity in its natural conformation. In our previous studies, 5 codon-optimized VP 1 DNA vaccines, including wt-VP 1, tPA-VP 1, VP l-d, VP 1-hFc and VP 1 - mFc, were constructed and analyzed. They expressed VP1 protein, but the levels of secretion and immunogenicity of these VP1 constructs were significantly different （P〈0.05）. In this study, we further investigated the protein lev- els of these constructs and determined that all of these constructs expressed VP1 protein. The secretion level was increased by including a tPA leader sequence, which was further increased by fusing human IgG Fc （hFc） to VP1. VP 1-hFc demonstrated the most potent immunogenicity in mice. Furthermore, hFc domain could be used to purify VPI-hFc protein for additional studies.
